+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Blood Brain Barrier"

Krabbe Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Krabbe Disease Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 194 Pages
  • Global
From
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 898 Pages
  • Global
From
From
RNAi Drug Delivery - Global Strategic Business Report - Product Thumbnail Image

RNAi Drug Delivery - Global Strategic Business Report

  • Report
  • July 2025
  • 294 Pages
  • Global
From
From
From
Brain Hemorrhage Pipeline Analysis Report 2025 - Product Thumbnail Image

Brain Hemorrhage Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Relapsing-Remitting Multiple Sclerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsing-Remitting Multiple Sclerosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Huntington's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Huntington's Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
X Linked Adrenoleukodystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

X Linked Adrenoleukodystrophy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Status Epilepticus - Pipeline Insight, 2025 - Product Thumbnail Image

Status Epilepticus - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Tay-Sachs Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Tay-Sachs Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Frontotemporal Dementia - Pipeline Insight, 2025 - Product Thumbnail Image

Frontotemporal Dementia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Charcot Marie Tooth Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Charcot Marie Tooth Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Neisseria Meningitides Meningitis - Pipeline Insight, 2025 - Product Thumbnail Image

Neisseria Meningitides Meningitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Leptomeningeal Disease -Pipeline Insight, 2025 - Product Thumbnail Image

Leptomeningeal Disease -Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Blood Brain Barrier (BBB) is a specialized membrane that separates the brain from the rest of the body. It is composed of tightly packed cells that form a barrier to protect the brain from potentially harmful substances. The BBB is an important factor in the development of Central Nervous System (CNS) drugs, as it can limit the effectiveness of certain drugs. To overcome this, drug developers must create drugs that can cross the BBB and reach the target area in the brain. This requires a deep understanding of the BBB and its components, as well as the development of new drug delivery systems. The BBB market is an important part of the CNS drug market, as it provides the necessary tools to develop effective drugs. Companies in this market include AbbVie, AstraZeneca, Biogen, Eli Lilly, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more